Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sukhjit Starch & Chemicals consolidated net profit rises 421.07% in the March 2026 quarter
Sales rise 11.66% to Rs 401.69 crore
Modison Ltd leads gainers in 'B' group
Hitech Corporation Ltd, Bliss GVS Pharma Ltd, Biofil Chemicals & Pharmaceuticals Ltd and Indo Rama Synthetics (India) Ltd are among the other gainers in the BSE's 'B' group today, 26 May 2026.
Healthcare, engineering and specialty chemicals remain key market themes: Mayuresh Joshi
Mayuresh Joshi, Director Research at Marketsmith India, believes execution will remain key for companies like Suzlon, while healthcare, engineering and select speciality chemical names continue to offer strong growth opportunities. He also sees India-focused engineering and capital goods companies remaining resilient despite global uncertainties. Joshi says investors should stay selective in IT, remains positive on Navin Fluorine, and is closely tracking niche AI-linked opportunities emerging in smaller tech firms.
Kanoria Chemicals & Industries reports consolidated net profit of Rs 31.62 crore in the March 2026 quarter
Sales decline 29.44% to Rs 304.39 crore
Adani Ent, Bajaj Auto, Voda Idea, 16 more BSE 500 stocks hit 52-week highs
Hindalco, KEI Industries, Polycab, Apollo Hospital, Anand Rathi Wealth, GE Vernova T&D, Manappuram Finance, Navin Flurochemicals, Torrent Pharma and J B Chemicals hit fresh life-time highs on Monday.
J B Chemicals & Pharmaceuticals Ltd rises for third consecutive session
J B Chemicals & Pharmaceuticals Ltd is quoting at Rs 2243.5, up 2.32% on the day as on 12:49 IST on the NSE. The stock is up 31.82% in last one year as compared to a 4.24% spurt in NIFTY and a 14.46% spurt in the Nifty Pharma index.
Anupam Rasayan to acquire up to 43 pc stake in Bliss GVS Pharma for around Rs 1,369 cr
Specialty chemicals maker Anupam Rasayan India is set to acquire up to 43.3% of Bliss GVS Pharma for an estimated Rs 1,369.51 crore, with an open offer for an additional 26%. This strategic move aims to strengthen Anupam Rasayan's presence across the pharmaceutical value chain, from key starting materials to finished dosage formulations.
Gujarat State Fertilizers & Chemicals consolidated net profit declines 27.32% in the March 2026 quarter
Sales rise 36.96% to Rs 2632.67 crore
Rashtriya Chemicals and Fertilizers jumps 9% on posting strong Q4 results
In the March quarter, Rashtriya Chemicals and Fertilizers reported net profit at ₹186.72 crore, as compared to ₹72.46 crore a year ago, up 157 per cent Y-o-Y
Rashtriya Chemicals & Fertilizers consolidated net profit rises 157.69% in the March 2026 quarter
Sales rise 49.63% to Rs 5580.57 crore
RCF shares jump 7% as Q4 profit soars 158% YoY to Rs 187 crore
Rashtriya Chemicals & Fertilizers shares rose sharply on Friday after the company's Q4FY26 results showed a 158% YoY surge in net profit to Rs 187 crore and a 49.6% rise in revenue. FY26 profit and revenue also grew strongly, while the company announced a Rs 1.34/share dividend, boosting investor sentiment despite muted long-term stock performance.
RCF rises as Q4 PAT skyrockets 158% YoY to Rs 187 crore
Rashtriya Chemicals & Fertilizers (RCF) rose 5.35% to Rs 131.90 after the company's consolidated net profit zoomed 157.69% to Rs 186.72 crore in Q4 FY26, compared with Rs 72.46 crore reported in the same period last year.